Healthcare

The Tissue Diagnostics (TDx) market is expected to reach $8,848.6 million in 2025, growing at a CAGR of 8.9% from 2020 to 2025. Advanced Staining and Anatomical Pathology Laboratory Information Management Systems (APLIS) will continue to grow at higher rates due to growing demand for personalized diagnosis and need for automation respectively. Wher...

Chronic diseases have continued to rise in prevalence, and the costs of managing these and treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behaviour change, several tools are necessary to sup...

The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on advanced therapeutics development for neurological disorders, oncology, immunological diseases. Peptide-drug conjugates, targeted antibodies, gene therapy, and cell therapies have also been discussed in this edition. Protein bioprinting, fiber-based c...

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of ph...

Globally, hospitals and health systems face financial pressure caused by high operating and administrative costs, declining revenue and reimbursement rates, and the increasing cost of both medical devices (due to technology advancements) and infrastructure. The COVID-19 pandemic has intensified this financial crisis as patient volumes dropped and n...

03 Sep 2021  |  North America

Global Renal Care Management Growth Opportunities

Value-based Renal Care to be a Key Growth Area

Infographics

×

The global prevalence of CKD is estimated to be about 9% to 10%. Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and mental ill hea...

Respiratory diseases are on the rise globally due to various factors, including environmental ones. Obstructive lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis are a huge burden on the global healthcare system. Existing therapies can only reduce the impact and provide short-term relief, but are not ca...

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...